Aripiprazole and Tablet Dosing
Links shared publicly online about this topic
Otsuka Pharmaceutical Europe Ltd Withdraws Its Application For An Extension Of Indication For Abilify (aripiprazole), Europe
medicalnewstoday.com — “The european medicines agency has been formally notified by otsuka pharmaceutical europe ltd of its decision to withdraw its application for an extension of indication for the centrally authorised” View full resource at medicalnewstoday.com
Most Recently Shared on November 20, 2009 at 11:41 am By:
Otsuka Pharmaceutical Europe Ltd Withdraws Its Application For An Extension Of Indication For Abilify (aripipra.. http://bit.ly/1QCH4R
Adding a low dose atypical antipsychotic drug to a... [Prog Neuropsychopharmacol Biol Psychiatry. 2010] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on May 19, 2010 at 2:45 pm By:
William Yates, M.D. Psychiatrist, Family Medicine Doctor, Physician, and Doctor
Aripiprazole antidepressant augmentation produces rapid increase in BDNF in treatment-resistant depression. http://ht.ly/1MQYN
Some Coumadin Tablets Recalled
healthcentral.com — “Some Coumadin Tablets Recalled” View full resource at healthcentral.com
Most Recently Shared on July 15, 2010 at 2:46 am By:
Some Coumadin Tablets Recalled http://sns.ly/yBk44
FDA Alert: Metronidazole Tablets, 250mg: Recall - Underweight Tablets
drugs.com — “FDA Alert: Metronidazole Tablets, 250mg: Recall - Underweight Tablets” View full resource at drugs.com
Most Recently Shared on January 8, 2011 at 5:17 am By:
FDA Alert - Recall: Teva Metronidazole 250mg - Underweight Tablets - http://bit.ly/hpjcor
FDA Alert: Metronidazole Tablets, 250mg: Recall - Underweight Tablets
drugs.com — “FDA Alert: Metronidazole Tablets, 250mg: Recall - Underweight Tablets” View full resource at drugs.com
Most Recently Shared on January 8, 2011 at 4:16 am By:
Drugs and Devices OW OW Health
Metronidazole Tablets, 250mg: Recall - Underweight Tablets: Audience: Pharmacy, Consumer [Posted 01/06/2011... http://bit.ly/hmeArp #FDA
FDA Alert: Propafenone HCl Tablets
drugs.com — “FDA Alert: Propafenone HCl Tablets” View full resource at drugs.com
Most Recently Shared on March 25, 2009 at 11:03 pm By:
FDA Alert: Propafenone HCl Tablets - http://tinyurl.com/d8w78z
Drugmaker Recalls Some Coumadin Tablets
healthcentral.com — “Drugmaker Recalls Some Coumadin Tablets” View full resource at healthcentral.com
Most Recently Shared on July 14, 2010 at 5:24 pm By:
Drugmaker Recalls Some Coumadin Tablets http://sns.ly/3Bp47
Treated with a Low Dose of Enjuvia Tablets can Reduce Hot Flashes | ThirdAge Articles
thirdage.com — “Teva Women's Health has presented data that demonstrated patients treated with a standard or low dose of Enjuvia tablets experienced statistically significant reductions in how often they were awakened at night by hot flashes. Learn more at Thirdage.com.” View full resource at thirdage.com
Most Recently Shared on June 7, 2010 at 4:38 pm By:
Treated with a Low Dose of Enjuvia Tablets can Reduce Hot Flashes http://bit.ly/asZMNB
Alkermes Announces Positive Results From Clinical Study Of ALKS 9070 For Treatment Of Schizophrenia - QualityPoint Technologies
qualitypointtech.net — “Alkermes, Inc. (NASDAQ: ALKS) today announced positive topline results from a phase 1b, double-blind, randomized, placebo-controlled study of ALKS 9070 in patients with schizophrenia. ALKS 9070, a proprietary Alkermes molecule for the treatment of schizophrenia, is designed to provide patients with once-monthly dosing of a medication that, once in the body, converts into aripiprazole, a molecule that is commercially available under the name ABILIFY® for the treatment of a number of central nervo” View full resource at qualitypointtech.net
Most Recently Shared on July 1, 2011 at 6:00 pm By:
Alkermes Announces Positive Results From Clinical Study Of ALKS 9070 For Treatment Of Schizophrenia: Alkermes, Inc... http://bit.ly/kd2y2o
OpEdNews - Article: Tracking the American Epidemic of Mental Illness - Part II
opednews.com — “A fortune can be made from these life-long antipsychotic customers. In April 2010, the price for one box of Invega, at a middle dose, was $1,373 at DrugStore.com. Risperdal went for $788 per 90 pills. The cost was $1,395 for 100 tablets of Abilify. Seroquel cost $997 per 100. One-hundred capsules of Geodon sold for $918 and Zyprexa cost $1,523 for a hundred 10mg pills.” View full resource at opednews.com
Most Recently Shared on June 3, 2010 at 5:38 am By:
Peter H Brown Doctor and Psychologist
Tracking the American Epidemic of Mental Illness - Part II http://bit.ly/cQtglM #psychosis #schizo
FDA Alert: Dextroamphetamine, Amphetamine 20mg Tablets
drugs.com — “FDA Alert: Dextroamphetamine, Amphetamine 20mg Tablets” View full resource at drugs.com
Most Recently Shared on August 15, 2009 at 2:45 am By:
FDA Alert - Voluntary Recall of Dextroamphetamine/Amphetamine 20mg Tablets - Barr Laboratories, Inc. - http://bit.ly/IqmNu
Bayer Low Dose 81 mg Aspirin Enteric Coated Tablets | Clayton CA Chiropractic
claytonchiropractic.org — “Bayer Low Dose 81 mg Aspirin Enteric Coated Tablets | Clayton CA Chiropractic” View full resource at claytonchiropractic.org
Most Recently Shared on April 1, 2011 at 8:00 am By:
Takeda Files NDA For Fixed-Dose Combination Tablet Of Actos With Sulfonylurea In Japan - Pharmaceutical Business Review
pharmaceutical-business-review.com — “Takeda Files NDA For Fixed-Dose Combination Tablet Of Actos With Sulfonylurea In Japan - Pharmaceutical Business Review” View full resource at pharmaceutical-business-review.com
Most Recently Shared on July 29, 2009 at 2:01 pm By:
eyeonfda Pharma and Health Lawyer
Takeda Files NDA For Fixed-Dose Combination Tablet Of Actos With Sulfonylurea In Japan http://bit.ly/5mFrh
BBC News - Splitting tablets 'may mean patients take wrong doses'
bbc.co.uk — “Patients who take their medication from tablets which are divided up could be at risk of taking incorrect doses a study suggests.” View full resource at bbc.co.uk
Most Recently Shared on January 8, 2011 at 3:34 pm By:
Nardo Manaloto Health Professional
Splitting tablets 'may mean patients take wrong doses' (a chance to #innovate current system) http://flne.ws/26335368 on Fluent News
Low-dose HRT patches carry less risk of stroke than tablets
physorg.com — “Hormone replacement therapy (HRT) skin patches containing low doses of oestrogen carry less risk of stroke than oral therapy and may represent a safer alternative to tablets, suggests a study published in the British Medical Journal today.” View full resource at physorg.com
Most Recently Shared on June 4, 2010 at 8:52 am By:
PhysOrg Health News Health News
Low-dose HRT patches carry less risk of stroke than tablets http://tw.physorg.com/194845949
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MNT Mental Health
The latest mental health news published daily. Articles from research centers, universities and prestigious journals.
-
William Yates, M.D.
Clinical Neuroscientist. Research Psychiatrist, Laureate Institute of Brain Research (laureateinstitute.org) Professor of Research, University of Oklahoma.
-
Health Line
Healthline provides free, doctor-reviewed health information on Hypertension (High Blood Pressure) and a variety of other diseases and conditions.
Advertisement
